Provenance Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
5,052
+114
+2% +$26.6K 0.12% 37
2026
Q1
$1.21M Sell
4,938
-9
-0.2% -$2.1K 0.13% 35
2025
Q4
$1.02M Sell
4,947
-40
-0.8% -$7.91K 0.11% 41
2025
Q3
$925K Sell
4,987
-52
-1% -$8.91K 0.12% 40
2025
Q2
$770K Sell
5,039
-2,342
-32% -$360K 0.11% 48
2025
Q1
$1.22M Sell
7,381
-4,840
-40% -$757K 0.18% 30
2024
Q4
$1.77M Sell
12,221
-2,006
-14% -$311K 0.23% 29
2024
Q3
$2.31M Buy
14,227
+3,446
+32% +$549K 0.29% 27
2024
Q2
$1.58M Buy
10,781
+58
+0.5% +$8.63K 0.22% 37
2024
Q1
$1.7M Buy
10,723
+425
+4% +$67.6K 0.24% 33
2023
Q4
$1.61M Buy
10,298
+376
+4% +$57.7K 0.22% 33
2023
Q3
$1.55M Buy
+9,922
New +$1.64M 0.25% 29

Other funds holding JNJ

Provenance Wealth Advisors's JNJ Position: Q2 2026 in Review

Provenance Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, buying an estimated $26.6K and bringing the position to 5,052 shares worth $1.28M. The position accounts for 0.12% of the portfolio, ranked #37.

Provenance Wealth Advisors first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.31M in Q3 2024. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Provenance Wealth Advisors held 5,052 shares of Johnson & Johnson worth $1.28M as of Q2 2026.
  • Provenance Wealth Advisors bought 114 Johnson & Johnson shares in Q2 2026, an estimated $26.6K.
  • Johnson & Johnson made up 0.12% of Provenance Wealth Advisors's portfolio in Q2 2026, its #37 holding.
  • Provenance Wealth Advisors first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
  • Provenance Wealth Advisors's Johnson & Johnson position peaked at $2.31M in Q3 2024.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.